Presence at 2018 Alzheimer’s Association International Conference

Faculty and junior investigators of the Michigan Alzheimer’s Disease Center are heading to the 2018 Alzheimer’s Association’s International Conference (AAIC) this weekend in Chicago, IL. AAIC is the world’s largest international conference focused on Alzheimer’s and dementia research. Our team has a large presence at the event with 23 faculty and junior investigators being represented in 8 presentations and 25 research posters. A complete list of our presence is available below.

Presentations

Dian-Tu Adaptive Prevention Trial Launch and Baseline Data

Sunday, July 22nd, 8:00 – 9:30AM at McCormick Place Room 183

 

Propagation and Diverse Effects of Disease-Specific Prion-like Tau Oligomeric Strains

Monday, July 23rd, 8:00 – 9:30AM at McCormick Place, Room 184

 

Task-Related fMRI Change after High-Definition Transcranial Direct Current Stimulation in Cognitively Intact Older Adults and Patients with MCI

Tuesday, July 24th, 8:00 – 9:30AM at McCormick Place Room 185

 

The Relationship between Tau PET and Other AD Biomarkers in Autosomal Dominant Alzheimer Disease

Tuesday, July 24th, 4:15 – 5:45PM at McCormick Place Room 196

 

A Biomarker-Based Nutritional Risk Index Explains the Heterogeneity in Rates of Cognitive Decline in the Multi-Domain Alzheimer Prevention Trial (MAPT)

Wednesday, July 25th, 8:00 – 9:30AM at McCormick Place Room 184

 

Psychosocial Outcomes of Apoe e4 Genotype Disclosure in the Generation Study

Wednesday, July 25th, 4:15 – 5:45PM at McCormick Place Room 179

 

US Race/Ethnic Minorities at High Cognitive Risk Use LESS Healthcare Resources

Thursday, July 26th, 11:45AM – 1:15PM at McCormick Place Room 184

 

The Lewy Body Dementia Association Research Centers of Excellence Program:Toward Optimizing Clinical Care and Clinical Trial Infrastructure

Thursday, July 26th, 8:30 – 10:00AM at McCormick Place Room 179

 

Contemporary Issues in Clinical Trials Methods

Friday, July 20th, 8:00AM – 5:00PM at Marriott Marquis Grand Horizon A

 

Posters

Comparing the Centiloid Scale for Pittsburgh Compound B and Florbetapir in Longitudinal PET Studies of Sporadic AD

Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1

 

The Relationship between Tau PET and Other AD Biomarkers in Autosomal Dominant AD

Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1

 

Memory System Functional Connectivity and Working Memory Performance in Subjective Memory Complaints

Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1

 

Diffusion Modeling to Evaluate the Utility of Cogstate in Differentiating Normal Elderly, Mild Cognitive Impairment, and Probable Alzheimer’s Disease

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Behavioral Randomized Controlled Trial (RCT) Using Internet-Based Social Interactions As a Tool to Enhance Cognitive Reserve

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Declining Dementia Incidence in the Monongahela Valley: Birth Cohort Analyses from the Movies and Myhat Studies

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Noradrenergic Mechanisms of Vascular and Neuronal Pathophysiology in Preclinical Alzheimer’s Disease

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

An Introduction and Overview to the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Impact of Patient Mild Cognitive Impairment on Physician Decision Making for Treatment

Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Diagnostic Utility of NIH Toolbox Cognition Battery in Older Adults with Amnestic Mild Cognitive Impairment

Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Impact of Mild Cognitive Impairment on Patient and Care Partner Preferences for Cardiovascular Treatment

Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

The Design, Evaluation and Reporting of Non-Pharmacological, Cognition-Oriented Treatments (COTs) for Older Adults: Results of an Experts Survey

Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Investigating the Role of Ubiquilin2 in Age-Related Neurodegeneration

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Comparing the Centiloid Scale for Pittsburgh Compound B and Florbetapir in Longitudinal PET Studies of Sporadic AD

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Cognitive Stimulation and Cognitive Function Among Middle-Aged and Older Hispanic/Latino Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Cognition-Oriented Treatments Article Library and Evaluation (CogTale): A Novel Online Platform for Cognitive Intervention Research Evaluation, Synthesis, and Translation

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

The Alzheimer’s Prevention Initiative (API) Program: Design and Development of an Apoe Counseling and Disclosure Program

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

RNA Binding Dictates TDP43-Mediated Toxicity in Models of ALS and Ftd

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

The Oxytocin Receptor and Vascular Cognitive Impairment: Potential As a Novel Therapeutic Target

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

The Interaction between Tau and Protein Phosphatase 1 Is Affected By P301L Mutation

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Tissue-Specific Genome-Wide Prediction of Genetically Regulated Gene Expression and Its Association with Neurocognitive Function in US Hispanics/Latinos

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Ubiquilin-2 Regulation of Tau and α-Synuclein in Neurodegenerative Disease

Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Pre-Statistical Harmonization of Cognitive Measures across Six Population-Based Cohorts: ARIC, Cardia, Chs, Fhs, MESA, and Nomas

Wednesday, July 25th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Strong Differentiation of Mild Cognitive Impairment and Alzheimer’s Disease Status Based on Functional Connectivity, Brain Graph Topology and Computer-Based Cognitive Assessment

Wednesday, July 25th, 9:30AM – 4:15PM at McCormick Place Hall F1

 

Following the conference, MADC Associate Director, Dr. Bruno Giordani will travel the state of Michigan to share the latest Alzheimer’s disease research with the public in a series of Research Nights from August 22nd – August 29th. These Research Nights are in partnership with the Alzheimer’s Association, Michigan Great Lakes chapter. More information regarding these events is available on our event calendar here.